Page last updated: 2024-08-23

diltiazem and Carcinoma, Non-Small Cell Lung

diltiazem has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiu, LY; Ko, JL; Lee, YJ; Sheu, GT; Tee, YT; Yang, TY1

Other Studies

1 other study(ies) available for diltiazem and Carcinoma, Non-Small Cell Lung

ArticleYear
L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
    Toxicology letters, 2010, Feb-15, Volume: 192, Issue:3

    Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Calcium Channel Blockers; Calcium Channels, L-Type; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Diltiazem; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Lung Neoplasms; Nifedipine; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Taxoids; Tubulin; Vincristine

2010